baber/WOPTO huggingface dataset:
Patent DE-69528812-D1 (DE)
Inventor: MATSUZAWA KUNIHIKO
IPC: B41J29/38
Filed: 1995-12-22
Granted: 2002-12-19
Abstract: A bidirectional printer interface comprises a print monitoring controller provided for a host unit for controlling a printer connected to the host unit to monitor a print state; an analyzer provided for the printer for analyzing environment data for setting a print environment and print data; a storage provided the printer for analyzing storing the print data analyzed by the analyzer; wherein the analyzer compares data in relation to a print environment included in the print data with the environment data stored in the storage to determine the presence of the difference therebetween, and if the difference between the data is detected, the analyzer transmits the content of the difference between the data to the host unit and wherein the printer monitoring controller notifies the user of the content of the difference between the data transmitted from the analyzer. <IMAGE>
Patent DE-69603962-D1 (DE)
Inventor: DEMOREST DAVID
IPC: G01N30/28
Filed: 1996-07-10
Granted: 1999-09-30
Abstract: Disclosed is a method for increasing the electroosmotic flow rate available for a silica surface. In the method, there is provided an electrophoretic channel which is defined by one or more silica surfaces. The surface(s) are contacted with an alkaline aqueous solution containing a solubilized silicate-monovalent metal complex in an amount effective to increase the acidity of the silica surface(s), as evidenced by a reduction in the average bulk pKa of the surface(s). The achieved increase in acidity is greater than would be obtained using an otherwise identical solution lacking said silicate. In one preferred embodiment, the monovalent metal used in the solution is Li+, Na+, or K+. Also disclosed is a method for increasing the acidity of a silica surface, by contacting the surface with an alkaline aqueous solution of the type noted above.
Patent DE-69612997-D1 (DE)
Inventor: KIM SOO
IPC: C23C16/40
Filed: 1996-12-03
Granted: 2001-06-28
Abstract: PCT No. PCT/KR96/00230 Sec. 371 Date May 29, 1998 Sec. 102(e) Date May 29, 1998 PCT Filed Dec. 3, 1996 PCT Pub. No. WO97/20963 PCT Pub. Date Jun. 12, 1997An aluminum oxide film is economically and conveniently deposited on a substrate by a process which comprises vaporizing a dialkylaluminum alkoxide compound at a temperature ranging from 0 to 25 DEG  C. and contacting the resulting vapor with said substrate heated to a temperature ranging from 300 to 600 DEG  C.
Patent DE-69614244-D1 (DE)
Inventor: LARSEN ANDRE
IPC: F16L15/00
Filed: 1996-02-01
Granted: 2001-09-06
Abstract: PCT No. PCT/DK96/00054 Sec. 371 Date Jun. 23, 1997 Sec. 102(e) Date Jun. 23, 1997 PCT Filed Feb. 1, 1996 PCT Pub. No. WO96/23999 PCT Pub. Date Aug. 8, 1996In a joint for joining a first and a second part so that these first and second parts maintain a predefined rotational position in relation to each other, where the joint comprises an internal thread (33) in the firs part (34), which internal thread has an inner end and an outer free end receiving an outer free end of a corresponding external thread (22) on the second part (21) which external thread has an inner end adjacent to the second part, the free end of the ridge and the inner end of the groove forming the threads are bounded by surfaces (27, 39) lying in a plane through the axis of the threads, and the length of the threads are so adapted that a plane end surface of the ridge of one thread engages the plane end surface of the groove of the other thread when the two parts are screwed together and occupy the predefined mutual rotational position.
Patent DE-69614276-D1 (DE)
Inventor: VENTURATI TERESA
IPC: B41N1/00
Filed: 1996-05-24
Granted: 2001-09-06
Abstract: PCT No. PCT/IT96/00105 Sec. 371 Date Aug. 5, 1998 Sec. 102(e) Date Aug. 5, 1998 PCT Filed May 24, 1996 PCT Pub. No. WO97/33759 PCT Pub. Date Sep. 18, 1997A process for preparing removable metal sleeve for gravure printing machines has been carried out in which after treating the lateral surface of the cylinder with a separator product and after associating protective strips in closure of the through holes of the lateral surface of the cylinder, the same is dipped into an electro-copper plating bath for forming a copper removable sleeve and axial removing of the copper sleeve is obtained by means of compressed air forced to form an air cushion between the cooper sleeve and the lateral surface of the cylinder and by means of a separator product used between the same copper sleeve and the cylinder.
Patent DE-69616515-D1 (DE)
Inventor: BERRYMAN ALAN
IPC: C07D275/06
Filed: 1996-01-26
Granted: 2001-12-06
Abstract: Novel benzothiazine dioxides which are antagonists of endothelin are described, as well as novel intermediates used in their preparation, methods for the preparation, and pharmaceutical compositions of the same, which are useful in treating elevated levels of endothelin, essential renovascular malignant and pulmonary hypertension, cerebral infarction, cerebral ischemia, congestive heart failure, and subarachnoid hemorrhage.
Patent DE-69624239-D1 (DE)
Inventor: YAYON AVNER
IPC: A61K39/00
Filed: 1996-06-12
Granted: 2002-11-14
Abstract: The present invention concerns fibroblast growth factor receptor 3 (FGFR3) as a novel marker for mesenchymal skeletal progenitor cells. By utilizing this novel marker it was possible both to identify and locate mesenchymal skeletal progenitor cells in a tissue, as well as to obtain a substantially pure culture of such cells. The pure culture of the mesenchymal skeletal progenitor cells may be used, optionally after various manipulations ex vivo, as an active ingredient in pharmaceutical compositions or implants for the purpose of bone and/or cartilage repair. FGFR3 may also be used as a marker for the identification and the localization of cartilage- and bone-derived tumors. Agents capable of binding to FGFR3 may also be used for targeting cytotoxic agents to cartillage- and bone-derived tumors.The present invention concerns fibroblast growth factor receptor 3 (FGFR3) as a novel marker for mesenchymal skeletal progenitor cells. By utilizing this novel marker it was possible both to identify and locate mesenchymal skeletal progenitor cells in a tissue, as well as to obtain a substantially pure culture of such cells. The pure culture of the mesenchymal skeletal progenitor cells may be used, optionally after various manipulations ex vivo, as an active ingredient in pharmaceutical compositions or implants for the purpose of bone and/or cartilage repair. FGFR3 may also be used as a marker for the identification and the localization of cartilage- and bone-derived tumors. Agents capable of binding to FGFR3 may also be used for targeting cytotoxic agents to cartillage- and bone-derived tumors.
Patent DE-69627464-D1 (DE)
Inventor: FINKEL PETER
IPC: A61K8/40
Filed: 1996-12-19
Granted: 2003-05-22
Abstract: The present invention relates to photostable cosmetic compositions for protecting the human skin against skin damages caused by light, on the basis of emulsifier-free emulsions (hydrodispersion gels) for stabilizing dibenzoylmethane derivatives, in particular 1-(4-tert.butylphenyl)-3-(4-methoxyphenyl)propane-1,3-dione against photodecomposition caused by UV.
Patent DE-69635940-D1 (DE)
Inventor: USALA ANTON-LEWS
IPC: A61F2/02
Filed: 1996-11-14
Granted: 2006-05-11
Abstract: A hydrogel matrix for the storage, manufacture, functional testing, and viral infection testing of cellular moieties comprises 0.001 to 100m M gelatin, such as denatured collagen, and 0.01 to 1000  mu M of a cryoprolector, for example dextran. The matrix may further comprise 0.01 to 30 mM of a nitric oxide inhibitor such as an L-arginine analog. The hydrogel matrix may for example be used in treatments to increase vascularization.
Patent DE-69638191-D1 (DE)
Inventor: JENSEN JOEL F
IPC: B25J15/04
Filed: 1996-06-05
Granted: 2010-07-15
Abstract: The invention is directed to manipulator assembly (2) for holding and manipulating a surgical instrument (14) in a telerobotic system. The manipulator assembly includes an instrument holder removably coupled to a drive assembly so that the holder can be sterilized. The assembly further includes a force sensing element (52) mounted distal to the holder and the drive assembly for detecting forces exerted on the surgical instrument and providing feedback to the surgeon. The invention is also directed to a system and method for releasably holding a surgical instrument (14). The system includes an instrument support for automatically locking mounting pins on the instrument within locking slots on the instrument holder to releasably couple the instrument to the holder. With a twist-lock motion, the surgeon can rapidly engage and disengage various instruments from the holder during a surgical procedure, such as open surgery, laparoscopy or thoracoscopy.
Patent DE-69709660-D1 (DE)
Inventor: AUGUSTE STEPHANE
IPC: A61L15/58
Filed: 1997-09-15
Granted: 2002-02-21
Abstract: PCT No. PCT/FR97/01621 Sec. 371 Date May 15, 1998 Sec. 102(e) Date May 15, 1998 PCT Filed Sep. 15, 1997 PCT Pub. No. WO98/10801 PCT Pub. Date Mar. 19, 1998The invention concerns a novel hydrophile adhesive mass to be used for medical purposes characterised in that said hydrophile adhesive mass comprises: (a) 10 to 35 parts by weight of sequenced poly(styrene/olefin/styrene) copolymer, in particular poly(styrene/isoprene/styrene), (b) 20 to 50 parts by weight of a tackifier resin, (c) 2 to 15 parts by weight of an acrylate polymer with a glass temperature less than -20 DEG  C., (d) 2 to 25 parts by weight of a plasticizer, in particular a plasticizing oil, (e) 20 to 50 parts by weight of a hydrocolloid, (f) 0.1 to 2 parts by weight of at least one antioxidant. The invention also concerns the use of this adhesive mass for making protective bandages, in particular for treating blisters, skin-deep dermo-epidermic lesions, exudative wounds and burns.
Patent DE-69712793-D1 (DE)
Inventor: LEHTINEN JUKKA
IPC: D21F5/00
Filed: 1997-12-09
Granted: 2002-06-27
Abstract: The invention relates to a method of and an apparatus for drying a fiber web, whereby the fiber web is dried in a cylinder drying unit (12) and in a band drier unit (11). The fiber web (5) is led from the cylinder drying unit (12) to the band drier unit (11) in such a way that it is easy to determine a desired dry content for the fiber web (5) in the cylinder drying unit (12) when the fiber web (5) is transferred to the band drier unit (11).
Patent DE-69716304-D1 (DE)
Inventor: KIM SUNG-IL
IPC: C08G65/26
Filed: 1997-01-17
Granted: 2002-11-14
Abstract: An improved process for Polytetramethylene-Ether-Glycol-Diesters of the formula R-CO-O(CH2-CH2-CH2-CH2-O)n-COR1, in which R and R1 are identical or different and are alkyl radicals or derivatives thereof, by polymerization of tetrahydrofuran in the presence of a heterogeneous polymerization catalyst and in the presence of a carboxylic anhydride. The use of aluminum silicate catalyst composed of acid-activated and calcinated natural halloysite instead of the known catalytic silicates as bentonite, zeolite or kaolinite. The new catalyst with a very long lifetime produces polymers having more uniform properties and narrow molecular weight distribution even with a relative impure monomer.
Patent DE-69717594-D1 (DE)
Inventor: LEGARE PIERRE
IPC: B32B5/26
Filed: 1997-04-29
Granted: 2003-01-16
Abstract: A composite filter media (100) includes a meltblown fiber material and a nonwoven filter web which are preferably attached to each other by needling the nonwoven filter web with the meltblown fiber material. A netting (104) is then attached by preferably needling the nonwoven filter web and meltblown through the netting (104).
Patent DE-69718968-D1 (DE)
Inventor: SATO ATSUSHI
IPC: C07D209/34
Filed: 1997-01-16
Granted: 2003-03-20
Abstract: The present invention is directed to an oxindole derivative represented by formula (1): <CHEM> (wherein R represents a methyl group or a methoxy group), and pharmaceuticals containing the compound. The compound exhibits excellent granulation inhibiting activity while providing minimal liver toxicity and is useful as a pharmaceutical in the prevention and treatment of articular rheumatism, arteriosclerosis, hepatocirrhosis, etc., and also in the prevention and treatment of arthrosis deformans, psoriasis, gout, nephritis, angiitis, inflammatory intestinal diseases (ulcerative colitis, Crohn's disease), bronchitis, and chronic granulomatosis, etc.
Patent DE-69723551-D1 (DE)
Inventor: BLAND D
IPC: B01D53/86
Filed: 1997-04-09
Granted: 2003-08-21
Abstract: An apparatus and process is provided for the removal of hydrogen sulfide from gases and for restoration of hydrogen sulfide removal capacity in nitrogen-treated carbonaceous chars which have become exhausted for hydrogen sulfide capacity when used for the removal of hydrogen sulfide from gas streams. The apparatus has a matrix of removable canisters which contain the nitrogen-treated carbonaceous chars. This process entails directing the gas containing hydrogen sulfide through the canister, washing the spent carbonaceous char with water by flushing/dynamic washing through the canister to remove the majority of the hydrogen sulfide reaction products. By the use of this process a significant proportion of the original hydrogen sulfide capacity of the nitrogen-treated carbonaceous char is recovered and the canisters can be recycled a large number of times.
Patent DE-69727896-D1 (DE)
Inventor: HIRSIMAEKI OLAVI
IPC: H01F38/30
Filed: 1997-12-02
Granted: 2004-04-08
Abstract: The invention concerns a current-meter transformer (100) provided with a current divider, which transformer comprises a current divider (111), which consists of a primary-conductor part (111a) and of a by-pass part (111b,111b'). In the current-meter transformer (100) the magnetic circuit consists of the core (113) of the current transformer (112) and of a secondary circuit (114). The by-pass part (111b, 111b') of the current divider (111) has been formed electrically symmetric, and the magnetic circuit of the current-meter transformer (100) has been formed symmetric in relation to an external magnetic field ( phi e). <IMAGE>
Patent DE-69740060-D1 (DE)
Inventor: PSILOGENIS MARY
IPC: A61K33/243
Filed: 1997-03-13
Granted: 2011-01-05
Abstract: The present invention is directed to a method for the prophylactic management of delayed emesis by the use of metoclopramide nasal spray.
Patent DE-69809786-D1 (DE)
Inventor: DELALU HENRI
IPC: C07D209/08
Filed: 1998-09-29
Granted: 2003-01-09
Abstract: The present invention relates to a process for the preparation of high-grade chloramine by the action of commercial eau de Javelle of 100 chlorometric degrees on a solution of ammonia in the presence of ammonium chloride. According to this process, the chloramine is obtained having a content greater than or equal to 2 mol L-1, that is to say, greater than or equal to 10.3%. The process can be carried out continuously or discontinuously.
Patent DE-69825260-D1 (DE)
Inventor: PRIETO A
IPC: A23L1/304
Filed: 1998-03-30
Granted: 2004-09-02
Abstract: A nutritional formulation containing an effective amount of Lacto-N-neoTetraose to simulate the growth and/or metabolic activity of Bifidobacterium is provided. A process of inhibiting bacterial infections caused by Bacteroides, Clostridium, and E. coli including the step of feeding the nutritional composition to a subject is also provided.
Patent DE-69829189-D1 (DE)
Inventor: GRIGLIATTI A
IPC: C12N9/64
Filed: 1998-03-26
Granted: 2005-04-07
Abstract: The invention provides insect shuttle vectors, and methods of using such vectors, for stably transforming disparate insect cell lines to express heterologous proteins. The invention provides a transformed insect cell selection system based on resistance to the bleomycin/phleomycin family of antibiotics, including the antibiotic Zeocin. Efficient promoters derived from baculovirus immediate early promoters are disclosed for use in directing expression of heterologous proteins, including selectable markers, in transformed insect cells of the invention. Transposon-based vectors are disclosed that provide inducible transposition to optimize heterologous protein expression and unobtrusive markers to facilitate selection of desired transformants.
Patent DE-69833627-D1 (DE)
Inventor: GEYER VOLKER
IPC: E06B9/24
Filed: 1998-05-06
Granted: 2006-04-27
Abstract: A glass pane unit is used for enhanced daylight illumination of rooms. It comprises at least two transparent sheets (1, 2) enclosing parallel light-deflecting curved lamellae (3) each with a convexly-curved end (4), facing the incident light. A light-scattering surface structure is included. The light-scattering surface structure (7) is embossed on one of the transparent sheets (2). Preferably, the sheets are plane silicate glass or polymethylmethacrylate (PMMA) sheets, with the structuring on one side. A plastic sheet lining may provide the structuring on silicate glass. The structuring comprises ridges or grooves transverse to the lamellae. These are sinusoidal with specific amplitude and height. Three transparent sheets may be used, the surface pattern facing into a gas filled interspace.
Patent DE-69903142-D1 (DE)
Inventor: BURROUGHS TREVOR
IPC: G11C13/04
Filed: 1999-03-23
Granted: 2002-10-31
Abstract: A high capacity three-dimensional, optically-addressed storage device comprises multiple layers 3,4,5 from which digital data stored in any given layer can be rapidly and reliably retrieved despite the proximity of data in neighbouring layers. Interrogating radiation is projected through the device orthogonally to the layers, in a flood beam or a beam defined by an electronic mask. The interrogating beam is repeatedly refocussed to reduce retrieval errors associated with beam spreading. A given layer is selected by illumination with a selecting beam projected across the layer to interact with optically sensitive material deposited at selected digital storage locations in the layer, so as to cause that material to absorb the radiation of the interrogating beam more strongly than it does in the absence of the selecting beam.
Patent DE-69906030-D1 (DE)
Inventor: KRIS JACK
IPC: G02C7/02
Filed: 1999-04-26
Granted: 2003-04-24
Abstract: A progressive ophthalmic lens element including a lens surface having an upper viewing zone having a surface to achieve a refracting power corresponding to distance vision, a lower viewing zone having a greater surface power than the upper viewing zone to achieve a refracting power corresponding to near vision, and an intermediate zon extending across the lens element having a surface power varying from that of the upper viewing zone to that of the lower viewing zone and including a corridor of relatively low surface astigmatism, the progressive ophthalmic lens element including progressive design elements selected to reduce myopia progression.
Patent DE-69911924-D1 (DE)
Inventor: LEE CHUNG KYUN
IPC: A45C13/00
Filed: 1999-02-09
Granted: 2003-11-13
Abstract: The present invention relates to a bag with a shock absorbing unit for protecting the bag's contents from external impacts. In the shock absorbing unit 1, upper and lower panels 2, 3 and the side shock absorbing member 4 include a plurality of air cells 5, 6, each of which is inflated with air and sealed. The shock absorbing unit 1 is either sewed or attached to a bag 10 having a soft or hard side surface in a detachable manner so as to absorb various external impacts from all directions when carrying the bag 10 and to receive the contents safely and conveniently. In addition, it also allows the contents to be easily taken out.
Patent DE-69922037-D1 (DE)
Inventor: BASAWAPATNA GANESH
IPC: H04H20/00
Filed: 1999-09-08
Granted: 2004-12-23
Abstract: A telecommunications system for providing telecommunication services to a plurality of users connected to a loop-through cable distribution architecture. The system includes a signal collection and transmission circuit or headend circuit for collecting and transmitting telecommunication signals to the user. In addition, the system comprises a signal distribution system or circuit operatively connected to the signal collection and transmission circuit for receiving and transmitting telecommunication signals therefrom and thereto. The system includes a user or customer interface device operatively connected to an associated signal distribution circuit for both receiving telecommunication signals from the associated signal distribution circuit and transmitting telecommunication signals to the associated signal distribution circuit. The signal distribution circuit is formed by a node having a plurality of output lines and a service module operatively connected to one of the node output lines. The service module further includes a signal splitter having a plurality of output lines, a user service module circuit operatively connected to one of the splitter output lines, and a processor control circuit operatively controlling the service module.
Patent DE-69923918-D1 (DE)
Inventor: OLSEN ROBERT
IPC: B65D67/02
Filed: 1999-11-18
Granted: 2005-04-07
Abstract: This invention relates to a package (1) of a plurality of containers (5) unitized with a flexible container carrier (10). The carrier (10) is constructed from a plastic planar sheet having a plurality of container receiving openings (20). At least one handle (30) is integrally formed with the sheet and removable along a handle tear line (40). A carrier tear line (50) extends across the sheet and enables the package (1) to be divided into sub-packages (2) depending upon merchandising requirements. One or more handles (30 or 35) are removed along the handle tear line (40), depending on the required configuration of the package. Preferably pack and pricing information (25) is provided on the handles (30,35) so that the remaining handle on each pack carries the appropriate pricing information (25) for the whole (1) or the divided (2) pack. <IMAGE>
Patent DE-69928924-D1 (DE)
Inventor: WIENER M
IPC: A61M31/00
Filed: 1999-05-21
Granted: 2006-01-19
Abstract: Methods and devices are disclosed for selective delivery of therapeutic substances to specific histologic or microanatomic areas of organs. Introduction of the therapeutic substance into a hollow organ space (such as an hepatobiliary duct or the gallbladder lumen) at a controlled pressure, volume or rate allows the substance to reach a predetermined cellular layer (such as the ephithelium or sub-epithelial space). The volume or flow rate of the substance can be controlled so that the intralumenal pressure reaches a predetermined threshold level beyond which subsequent subepithelial delivery of the substance occurs. Alternatively, a lower pressure is selected that does not exceed the threshold level, so that delivery occurs substantially only to the epithelial layer. Such site specific delivery of therapeutic agents permits localized delivery of substances (for example to the interstitial tissue of an organ) in concentrations that may otherwise produce systemic toxicity. Occlusion of venous or lymphatic drainage from the organ can also help prevent systemic administration of therapeutic substances, and increase selective delivery to superficial epithelial cellular layers. Delivery of genetic vectors can also be better targeted to cells where gene expression is desired. The access device comprises a cannula with a wall piercing tracar within the lumen. Two axially spaced inflatable balloons engage the wall securing the cannula and sealing the puncture site. A catheter equipped with an occlusion balloon is guided through the cannula to the location where the therapeutic substance is to be delivered.